Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Fagerström

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 4, 2003
New perspectives in the treatment of tobacco dependenceKarl Fagerström
Respiration; International Review of Thoracic Diseases|September 17, 2002
Quit or die: nothing in between?Karl Fagerström
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 26, 2011
Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette DependenceKarl Fagerström
Drugs|July 12, 2002
The epidemiology of smoking: health consequences and benefits of cessationKarl Fagerström
Respiration; International Review of Thoracic Diseases|February 15, 2002
What is new with tobacco dependenceKarl Fagerström
Harm Reduction Journal|December 1, 2022
Can alternative nicotine products put the final nail in the smoking coffin?Karl Fagerström
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 9, 2005
The nicotine market: an attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countriesKarl Fagerström
Neuropsychiatric Disease and Treatment|August 30, 2008
Varenicline in the treatment of tobacco dependenceKarl Fagerström, John Hughes
The American Journal of Psychiatry|April 3, 2013
Reduced binding to nicotinic receptors after nicotine vaccination: is the effect big enough to be clinically meaningful?Karl Fagerström, Serena Tonstad
Clinics in Occupational and Environmental Medicine|February 1, 2006
Current trends in international tobacco controlFrancis Thompson, Karl Fagerström
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 4, 2003
New perspectives in the treatment of tobacco dependenceKarl Fagerström
Respiration; International Review of Thoracic Diseases|September 17, 2002
Quit or die: nothing in between?Karl Fagerström
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 26, 2011
Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette DependenceKarl Fagerström
Drugs|July 12, 2002
The epidemiology of smoking: health consequences and benefits of cessationKarl Fagerström
Respiration; International Review of Thoracic Diseases|February 15, 2002
What is new with tobacco dependenceKarl Fagerström
Harm Reduction Journal|December 1, 2022
Can alternative nicotine products put the final nail in the smoking coffin?Karl Fagerström
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 9, 2005
The nicotine market: an attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countriesKarl Fagerström
Neuropsychiatric Disease and Treatment|August 30, 2008
Varenicline in the treatment of tobacco dependenceKarl Fagerström, John Hughes
The American Journal of Psychiatry|April 3, 2013
Reduced binding to nicotinic receptors after nicotine vaccination: is the effect big enough to be clinically meaningful?Karl Fagerström, Serena Tonstad
Clinics in Occupational and Environmental Medicine|February 1, 2006
Current trends in international tobacco controlFrancis Thompson, Karl Fagerström
Pageof 4